Research Article
Potassium Concentration on Admission Is an Independent Risk Factor for Target Lesion Revascularization in Acute Myocardial Infarction
Table 3
Clinical characteristics of the patients at followup.
| | | Low K (<3.9) | Mid K (≥3.9, <4.3) | High K (≥4.3) | value | | | |
| | Time from PCI to followup (day) | | | | | | Target lesion revascularization (%) | 14 (15.2) | 21 (22.8) | 29 (31.5) | 0.0321 | | T-C at followup (mg/dL) | | | | | | HDL-C at followup (mg/dL) | | | | | | LDL-C at followup (mg/dL) | | | | | | TG at followup (mg/dL) | | | | | | Active medical treatment | | | | | | Aspirin | 92 (100) | 91 (98.9) | 92 (100) | 0.367 | | ACE-I/ARB | 79 (85.9) | 81 (88.0) | 71 (77.2) | 0.108 | | Beta-blocker | 27 (29.3) | 29 (31.5) | 33 (35.9) | 0.629 | | CaCB | 29 (31.5) | 27 (29.3) | 26 (28.3) | 0.886 | | Nitrate | 16 (17.4) | 16 (17.4) | 21 (22.8) | 0.558 | | Diuretics | 14 (15.2) | 12 (13.0) | 18 (19.6) | 0.469 | | Statin | 71 (77.2) | 67 (72.8) | 61 (66.3) | 0.254 |
|
|
PCI: percutaneous coronary intervention; T-C: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; ACE-I: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CaCB: calcium channel blocker.
|
